Are AI tools reliable enough to be used at in commercial settings? If so, should they be given “autonomy” to make decisions? These are the questions being raised after at least two internet outages at ...

Bristol Myers Squibb could be months away from bringing the first 'celmod' to market in the US, after the FDA kicked off a review of the company's iberdomide for relapsed or refractory multiple ...

President Trump suggested in an interview with former FBI Deputy Director Dan Bongino on Monday that Republicans should “take over” the voting process in more than a dozen states ahead of the November ...

The original version of the UNO Q paired Qualcomm’s Dragonwing QRB2210 processor with 2GB of RAM and 16GB of storage. A little over three months after it was announced alongside Qualcomm’s acquisition ...

WASHINGTON — Multiple employees at the Department of Labor have been placed on leave pending an inspector general’s investigation into alleged misconduct by Secretary Lori Chavez-DeRemer, according to ...

2025 would go down in history as a good year for equities, but also a period when certain risks became apparent. Supportive macroeconomic conditions will likely remain in 2026 and so far there are no ...

There's more to watch than ever before, but perhaps you still find yourself idly flicking through the “What's New” carousel on Netflix and not seeing anything that really grabs you … so then you do ...

Sanofi SAN-0.86%decrease; red down pointing triangle shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key ...

Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...